Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    G(-) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice.

    Mahamed DA, Marleau A, Alnaeeli M, Singh B, Zhang X, Penninger JM, Teng YT.

    Diabetes. 2005 May;54(5):1477-86.PMID: 15855336 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.

    Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, Penninger JM.

    J Clin Invest. 2000 Sep;106(6):R59-67.PMID: 10995794 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.

    Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS.

    Oral Microbiol Immunol. 2006 Feb;21(1):12-20.PMID: 16390336 [PubMed - indexed for MEDLINE]Related articles

    5.

    Immune response: the key to bone resorption in periodontal disease.

    Taubman MA, Valverde P, Han X, Kawai T.

    J Periodontol. 2005 Nov;76(11 Suppl):2033-41. Review.PMID: 16277573 [PubMed - indexed for MEDLINE]Related articles

    6.

    Bacterial-responsive B lymphocytes induce periodontal bone resorption.

    Han X, Kawai T, Eastcott JW, Taubman MA.

    J Immunol. 2006 Jan 1;176(1):625-31.PMID: 16365458 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.

    Valverde P, Kawai T, Taubman MA.

    J Bone Miner Res. 2004 Jan;19(1):155-64.PMID: 14753747 [PubMed - indexed for MEDLINE]Related articles

    8.

    The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.

    Belibasakis GN, Johansson A, Wang Y, Chen C, Kalfas S, Lerner UH.

    Infect Immun. 2005 Jan;73(1):342-51.PMID: 15618171 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model.

    Kawai T, Paster BJ, Komatsuzawa H, Ernst CW, Goncalves RB, Sasaki H, Ouhara K, Stashenko PP, Sugai M, Taubman MA.

    Oral Microbiol Immunol. 2007 Jun;22(3):208-15.PMID: 17488448 [PubMed - indexed for MEDLINE]Related articles

    11.
    13.

    Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection.

    Trombone AP, Ferreira SB Jr, Raimundo FM, de Moura KC, Avila-Campos MJ, Silva JS, Campanelli AP, De Franco M, Garlet GP.

    J Periodontal Res. 2009 Aug;44(4):443-51. Epub 2008 Oct 7.PMID: 18973535 [PubMed - indexed for MEDLINE]Related articles

    14.

    The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction.

    Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS.

    Clin Exp Immunol. 2007 Jan;147(1):128-38.PMID: 17177972 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice.

    Maruyama K, Takada Y, Ray N, Kishimoto Y, Penninger JM, Yasuda H, Matsuo K.

    J Immunol. 2006 Sep 15;177(6):3799-805.PMID: 16951341 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis.

    Ohazama A, Courtney JM, Sharpe PT.

    J Dent Res. 2004 Mar;83(3):241-4.PMID: 14981127 [PubMed - indexed for MEDLINE]Related articles

    17.

    Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss.

    Zhang X, Alnaeeli M, Singh B, Teng YT.

    Infect Immun. 2009 May;77(5):2000-9. Epub 2009 Mar 2.PMID: 19255186 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

    Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM.

    Nature. 1999 Nov 18;402(6759):304-9.PMID: 10580503 [PubMed - indexed for MEDLINE]Related articles

    19.

    Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.

    Kostenuik PJ.

    Curr Opin Pharmacol. 2005 Dec;5(6):618-25. Epub 2005 Sep 26. Review.PMID: 16188502 [PubMed - indexed for MEDLINE]Related articles

    20.

    Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.

    Yamamoto Y, Udagawa N, Matsuura S, Nakamichi Y, Horiuchi H, Hosoya A, Nakamura M, Ozawa H, Takaoka K, Penninger JM, Noguchi T, Takahashi N.

    Endocrinology. 2006 Jul;147(7):3366-74. Epub 2006 Apr 20.PMID: 16627581 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data